Hypersensitivity reactions with ARCALYST were administration administration. Please see the full Prescribing Information for ARCALYST, Forward Looking Statements About Regeneron Pharmaceuticals.. ARCALYST is for the treatment of cryopyrin-associated periodic syndromes , over 12. Including Familial Cold Auto – inflammatory Syndrome and Muckle-Wells syndrome in adults and children over 12. IL-1 blockade may interfere with immune response to infections. Life-threatening infections were in patients who ARCALYST been reported. ARCALYST should be discontinued if a patient develops a serious infection will. Under ARCALYST with tumor necrosis factor inhibitors is not recommended because this of serious infections of serious infections.
Schleifer, Regeneron ‘s President and Chief Executive Officer. ‘We recognize that ARCALYST may help address a significant unmet medical need that exists among CAPS patients and help therefore, these patients have access to this new treatment required. ‘.
, and fatigue.Regeneron ARCALYST for the treatment of cryopyrin-associated periodic syndromes CAPS of life, marked recurrent symptoms of rash, fever / chills, joint pain, eye redness / pain, and fatigue. Intermittent, disruptive exacerbations or flares can be triggered at any time by exposure to cooling temperatures, exercise, or other unknown stimuli.. Is a targeted ARCALYST inhibitor of interleukin – 1 , the main drivers of inflammation in CAPS.